VF Hemp Oil Liquid - 6 pack, plus counter display

VF Hemp Oil is a hemp oil for cats and dogs that provides plant-derived cannabinoids — known as phytocannabinoids — to support pets’ endocannabinoid systems (ECS).

• Formulated for dogs and cats
• Liquid form — convenient, flexible dosing with a graduated dropper
• 1 mL delivers 15 mg of phytocannabinoids^, which support the endocannabinoid system

For pets and people alike, the endocannabinoid system (ECS) is perhaps the most important physiological system involved in establishing and maintaining optimal health. This ubiquitous system mediates a homeostatic balance of the nervous and immune systems in conjunction with other organ systems.^1-4  The physiological effects of cannabinoids and their respective cannabinoid receptors are common among all mammals⁵— a well-balanced ECS is associated with favorable health outcomes, while imbalance is often associated with a variety of health challenges.³

How to Administer

Based on body weight, the canine or feline patient should receive the formula according to the following recommendations, or as otherwise directed.

Dog Daily Dose Schedule†

<5 lbs.	0.25 mL every other day
5-9 lbs.	0.25 mL
10-19 lbs.	0.50 mL
20-29 lbs.	0.75 mL
30-39 lbs.	1.00 mL
40-49 lbs.	1.25 mL
50-59 lbs.	1.50 mL
60-69 lbs.	1.75 mL
70-79 lbs.	2.00 mL
80-89 lbs.	2.25 mL
90-99 lbs.	2.50 mL
100-110 lbs.	2.75 mL

†Or as directed by your veterinarian.

Cat Daily Dose Schedule†

<7 lbs.	0.25 mL every other day
7-11 lbs.	0.25 mL
12-17 lbs.	0.50 mL
18-25 lbs.	0.75 mL

†Or as directed by your veterinarian.

References:

1.  Silver R J. Animals (Basel). 2019 Sep; 9(9): 686. doi: 10.3390/ani9090686
2. Ritter S, Zadik-Weiss L, Almogi-Hazan O and Or R. Rambam Maimonides Med J. 2020; 11(1) e0006 Rambam Maimonides Med J | www.rmmj.org.il
3. Pertwee, R. G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacology & therapeutics 74, 129-180 (1997).
4. Institute of, M. Marijuana and Medicine: Assessing the Science Base.  (The National Academies Press, 1999).
5. Di Marzo V, Piscitelli F. Neurotherapeutics. 2015;12(4):692–698. doi:10.1007/s13311-015-0374-6.